Performance vs S&P 500

03
Tracked Q1 2025–Q2 2026 -27.4%
S&P 500 total return (same window) +37.0%
Excess return -64.4%

Annualized: -22.6% · S&P 500: +28.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

04
Healthcare 100.0%

Full portfolio 5 positions

05
Type Streak 8Q trend
BVS Bioventus Inc. - Class A Common Stock $122,921,299 48.35% 13,021,324 $4,036,611
MDXG MiMedx Group, Inc - Common Stock $108,551,709 42.70% 28,195,249 $-2,819,525
EYPT EyePoint, Inc. - Common Stock $15,513,455 6.10% 1,084,857 $1,529,648
TELA TELA Bio, Inc. - Common stock $5,786,032 2.28% 7,714,709 $1,002,912
MNOV MediciNova, Inc. - Common Stock $1,459,842 0.57% 1,105,941 $-55,297

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
BVS Price move only +0 +$4.0M
MDXG Price move only +0 -$2.8M
EYPT Price move only +0 +$1.5M
TELA Price move only +0 +$1.0M
MNOV Price move only +0 -$55K

Exited positions

11

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarterShares beforeValue beforePrice since exit
VERO March 31, 2026 99,021 $146,551 No longer tracked